Search

everythinglearnresearchcommunity

for

Search:↓

The article helps identify common, non-harmful skin conditions in newborns to avoid undue concern and treatment.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

Hormones and stretching both needed for nipple area skin growth in mice.

Finasteride may cause lasting sexual side effects, but more research is needed.

Finasteride may cause long-lasting sexual side effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Certain medications can reduce sexual desire and function, especially in women.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.